Clinical Trial Update: Current Status of Cardiovascular Diseases in Chinese Overweight/ Obesity Population: An Epidemiological Study (COPE）

View source ↗

Summary

A completed epidemiological study led by Novo Nordisk A/S examining cardiovascular disease status among Chinese adults who are overweight or obese.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Status: COMPLETED